Drugs / Esmketamine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT04877639 Comparator | May 2021 → Dec 2022 | — | Zhongnan Hospital | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Esmketamine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04877639 ↗ |
| Route | Intravenous | “Group K received a 1.0 mg/kg IV bolus of esketamine over 10 s followed by the infusion rate 1 mg/kg/hr to the end of DISE.” PMID 36532775 ↗ Dec 2022 |